Indefinite Delivery Contract SPE2D220D0101

Award Date 9/16/20
Last Date to Order 9/15/25
Federal Agency
Medical Supply Chain
Awardee
Avkare LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $16,701,923.95 and a period of performance through December 7, 2026. The contract is for the manufacture and distribution of pharmaceutical and medical supplies, primarily generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...
The Indefinite Delivery Contract (IDC) SPE2D222D0144 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award contract has a ceiling value of $14,460,136.05 and a period of performance through May 3, 2027. Under this IDC, Avkare will manufacture and distribute a variety of pharmaceutical and medical products, including generic drugs such as cephalexin, prednisone,...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee, has a ceiling value of $3,798,662.40 and a period of performance through April 26, 2025. The contract is for the manufacture and distribution of pharmaceutical and medical products, primarily consisting of generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $62,144,789.65 contract has a period of performance through April 2025 and allows the DLA, Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BOP) to issue task orders for a variety of pharmaceutical and medical products. The original solicitation sought offers for a...
The federal contract IDV award SPE2D222D0143 was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to the prime contractor Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The single-award IDC, valued at $4,256,797.10, covers the manufacture and distribution of a variety of generic pharmaceutical products such as cephalexin capsules, emtricitabine-tenofovir tablets, primaquine phosphate tablets, and sulfamethoxazole-trimethoprim tablets, among others....
The federal contract IDV award SPE2D225D0002 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $8,147,325.32 and a period of performance through January 30, 2025. The contract provides for the delivery of a variety of generic medications and medical supplies to federal agencies including the Department of Defense (DoD), Department of...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Avkare, LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $1,244,773.20 and a performance period from July 15, 2024 to July 14, 2025, with four one-year option periods. The contract aims to provide a wide range of pharmaceutical and medical products to support the healthcare missions of the Department of Veterans Affairs (VA), Department...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded Avkare, LLC, a for-profit limited liability company, a single award indefinite delivery contract (IDC) to provide pharmaceutical products and medical supplies to the U.S. Department of Defense, Department of Veterans Affairs, and other federal healthcare agencies. The contract has a ceiling value of $4,897,608.76 and will run through March 7, 2033. Under this IDC, Avkare has received numerous firm-fixed price delivery orders to...
The federal contract IDV award SPE2D219D0074 is a single-award indefinite delivery contract held by the pharmaceutical and medical supply company Avkare LLC. The contract, with a ceiling value of $21,217,720.50, was awarded on June 25, 2019 by the Defense Logistics Agency (DLA) Troop Support Medical to provide a national supply source for various pharmaceutical and medical products. The contract primarily consists of the manufacture and distribution of generic pharmaceutical products such as...

The Indefinite Delivery Contract (IDC) SPE2D220D0101 was awarded to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $5,934,599.30 single-award contract was issued by the Defense Logistics Agency (DLA) to provide a national supply source for various pharmaceutical products, including generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and sulfamethoxazole-trimethoprim. The contract has a base period of one year with four one-year option periods, allowing the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons to issue task and delivery orders for these medical supplies on an as-needed basis. The contract was the result of a pre-solicitation by the DLA for a requirements-type contract to provide Anastrozole 1MG tablets in 30 and 90 count bottles to various federal healthcare agencies through the DLA and VA prime vendor programs. The solicitation was open to all sources, with no small business set-asides used, indicating Avkare's capability to meet the government's procurement requirements.

Generated 3/23/25, 1:04 AM